Abbott Laboratories vs. Omeros Corporation
Abbott Laboratories (ABT) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| ABT | OMER | |
|---|---|---|
| Market Cap | $198.01 billion | $1.33 billion |
| Revenue (TTM) | $46.59 billion | $38.42 million |
| Net Income (TTM) | $5.42 billion | $124.83 million |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | OMER | |
|---|---|---|
| P/E Ratio | 37.66 | 11.21 |
| Price / Book | 3.83 | -25.92 |
| Price / Sales | 4.25 | 34.65 |
OMER leads on 2 of 3 valuation factors.
Profitability
| ABT | OMER | |
|---|---|---|
| Net Margin | 11.65% | 324.88% |
| Return on Equity | 10.48% | -243.09% |
ABT and OMER split the profitability factors evenly.
Dividend
| ABT | OMER | |
|---|---|---|
| Dividend Yield | 2.17% | — |
| Payout Ratio | 81.55 | — |
ABT and OMER split the dividend factors evenly.
Risk & Sentiment
| ABT | OMER | |
|---|---|---|
| Short Interest | 0.57% | 9.61% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, OMER overview, OMER financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.